Table 1.
T-test and chi-square models of demographics, drug use characteristics, and engagement in overdose prevention among people who inject drugs by race
| Characteristic | Number (%) | p-value | ||
|---|---|---|---|---|
| Total (N = 372) | Black (N = 203) | White (N = 169) | ||
| Sex, Male | 249 (67) | 132 (65) | 117 (69) | 0.391 |
| Age, mean (SD) | 44 (11) | 49 (10) | 38 (9) | < 0.001 |
| Education, graduated high school | 245 (66) | 116 (57) | 129 (76) | < 0.001 |
| Homelessness in the past 6 months | 214 (58) | 95 (47) | 119 (70) | < 0.001 |
| Injection drug recency | ||||
| 6 to 12 months ago | 32 (9) | 19 (9) | 13 (8) | 0.499 |
| 4 to 6 months ago | 25 (7) | 16 (8) | 9 (5) | |
| In past 3 months | 315 (85) | 168 (83) | 147 (87) | |
| Opioid agonist treatment | 234 (63) | 120 (59) | 114 (67) | 0.097 |
| Engagement in needle exchange (n = 340) | 169 (50) | 94 (51) | 75 (48) | 0.580 |
| Number of witnessed overdoses, mean (SD) | 9 (16) | 9 (19) | 8 (13) | 0.707 |
| Number of personal overdoses, mean (SD) | 3 (4) | 2 (3) | 4 (5) | < 0.001 |
| Naloxone access | 268 (72) | 130 (64) | 138 (82) | < 0.001 |
| Trained to use naloxone | 243 (65) | 117 (58) | 126 (75) | 0.001 |
| Used naloxone (n = 345) | 162 (47) | 67 (36) | 95 (60) | < 0.001 |